Cadrenal Therapeutics raises $3M in private placement; warrants add up to $5.8M

Cadrenal Therapeutics, Inc.

Gross proceeds of $3M from sale of 960,000 pre-funded warrants at $3.1249/unit.
Issued series C-1 and C-2 warrants to purchase up to 960,000 shares each at $3.00.
Net proceeds to extend cash runway into Q1 2027; if warrants fully exercised, into H2 2027.
H.C. Wainwright acted as exclusive placement agent; officers/directors subject to 60-day lock-up.
Private placement closed July 1, 2026; securities unregistered, resale registration to be filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.